Defective anchoring of JNK1 in the cytoplasm by MKK7 in Jurkat cells is associated with resistance to Fas-mediated apoptosis

Molecular Biology of the Cell

Volumn 22, Issue 1, 2011, Pages 117-127

  Wang, Jing ^a   Tang, Ruihong ^a   Lv, Ming ^a   Wang, Qingyang ^a   Zhang, Xueying ^a   Guo, Yuanyuan ^a   Chang, Hong ^a   Qiao, Chunxia ^a   Xiao, He ^a   Li, Xinying ^a   Li, Yan ^a   Shen, Beifen ^a   Zhang, Jiyan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; STRESS ACTIVATED PROTEIN KINASE 1; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

APOPTOSIS; ARTICLE; CELL ANCHORAGE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; ULTRAVIOLET RADIATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; JURKAT CELLS; MAP KINASE KINASE 7; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 8; NIH 3T3 CELLS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; T-LYMPHOCYTES;

EID: 78651090290     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-06-0492     Document Type: Article

References (41)

1. Amagasaki K, Kaneto H, Heldin CH, Lennartsson J (2006). c-Jun N-terminal kinase is necessary for platelet-derived growth factor-mediated chemotaxis in primary fi broblasts. J Biol Chem 281, 22173-22179.
2. Bardwell AJ, Frankson E, Bardwell L (2009). Selectivity of docking sites in MAPK kinases. J Biol Chem 284, 13165-13173.
3. Ben-Levy R, Hooper S, Wilson R, Paterson HF, Marshall CJ (1998). Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol 8, 1049-1057.
4. Bjorkblom B, Ostman N, Hongisto V, Komarovski V, Filen JJ, Nyman TA, Kallunki T, Courtney MJ, Coffey ET (2005). Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector. J Neurosci 25, 6350-6361.
5. Bruna A, Nicolas M, Munoz A, Kyriakis JM, Caelles C (2003). Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids. EMBO J 22, 6035-6044. (Pubitemid 37463247)
6. Cavigelli M, Dolfi F, Claret FX, Karin M (1995). Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J 14, 5957-5964.
7. Chang L, Karin M (2001). Mammalian MAP kinase signalling cascades. Nature 410, 37-40.
8. Chen Y, Ciustea M, Ricciardi RP (2005). Processivity factor of KSHV contains a nuclear localization signal and binding domains for transporting viral DNA polymerase into the nucleus. Virology 340, 183-191. (Pubitemid 41317493)
9. Chuderland D, Konson A, Seger R (2008). Identifi cation and characterization of a general nuclear translocation signal in signaling proteins. Mol Cell 31, 850-861.
10. Costa M, Marchi M, Cardarelli F, Roy A, Beltram F, Maffei L, Ratto GM (2006). Dynamic regulation of ERK2 nuclear translocation and mobility in living cells. J Cell Sci 119, 4952-4963.
11. Cui J, Wang Q, Wang J, Lv M, Zhu N, Li Y, Feng J, Shen B, Zhang J (2009). Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells. Mol Cancer Ther 8, 3214-3222.
12. Fukuda M, Gotoh Y, Nishida E (1997). Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase. EMBO J 16, 1901-1908.
13. Gendron S, Couture J, Aoudjit F (2003). Integrin α2β1 inhibits Fas-mediated apoptosis in T lymphocytes by protein phosphatase 2A-dependent activation of the MAPK/ERK pathway. J Biol Chem 278, 48633-48643. (Pubitemid 41079502)
14. Guo L, Guo Y, Xiao S, Shi X (2005). Protein kinase p-JNK is correlated with the activation of AP-1 and its associated Jun family proteins in hepatocellular carcinoma. Life Sci 77, 1869-1878.
15. Hibi M, Lin A, Smeal T, Minden A, Karin M (1993). Identifi cation of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7, 2135-2148.
16. Ho DT, Bardwell AJ, Grewal S, Iverson C, Bardwell L (2006). Interacting JNK-docking sites in MKK7 promote binding and activation of JNK mitogen-activated protein kinases. J Biol Chem 281, 13169-13179.
17. Hui L, Bakiri L, Mairhorfer A, Schweifer N, Haslinger C, Kenner L, Komnenovic V, Scheuch H, Beug H, Wagner EF (2007). p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat Genet 39, 741-749.
18. Karin M (1995). The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270, 16483-16486.
19. Lenormand P, Sardet C, Pages G, L'Allemain G, Brunet A, Pouyssegur J (1993). Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fi broblasts. J Cell Biol 122, 1079-1088. (Pubitemid 23254175)
20. Lin A (2003). Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 25, 17-24.
21. Low W, Smith A, Ashworth A, Collins M (1999). JNK activation is not required for Fas-mediated apoptosis. Oncogene 18, 3737-3741.
22. Lu C, Zhu F, Cho YY, Tang F, Zykova T, Ma WY, Bode AM, Dong Z (2006). Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol Cell 23, 121-132.
23. McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, Lin FT, Davis RJ, Lefkowitz RJ (2000). Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290, 1574-1577.
24. Mignon A, Guidotti JE, Mitchell C, Fabre M, Wernet A, De La Coste A, Soubrane O, Gilgenkrantz H, Kahn A (1998). Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes. Nat Med 4, 1185-1188.
25. Oleinik NV, Krupenko NI, Krupenko SA (2007). Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway. Oncogene 26, 7222-7230.
26. Raman M, Chen W, Cobb MH (2007). Differential regulation and properties of MAPKs. Oncogene 26, 3100-3112.
27. Reszka AA, Seger R, Diltz CD, Krebs EG, Fischer EH (1995). Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci USA 92, 8881-8885.
28. Schwabe RF, Uchinami H, Qian T, Bennett BL, Lemasters JJ, Brenner DA (2004). Differential requirement for c-Jun NH2-terminal kinase in TNF-α-and Fas-mediated apoptosis in hepatocytes. FASEB J 18, 720-722.
29. Suganuma T, Mushegian A, Swanson SK, Abmayr SM, Florens L, Washburn MP, Workman JL (2010). The ATAC acetyltransferase complex coordinates MAP kinases. Cell 142, 726-736.
30. Tararuk T et al. (2006). JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length. J Cell Biol 173, 265-277.
31. Tournier C, Dong C, Turner TK, Jones SN, Flavell RA, Davis RJ (2001). MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev 15, 1419-1426.
32. Tournier C, Whitmarsh AJ, Cavanagh J, Barrett T, Davis RJ (1999). The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases. Mol Cell Biol 19, 1569-1581.
33. Weir BA et al. (2007). Characterizing the cancer genome in lung adenocarcinoma. Nature 450, 893-898.
34. Weston CR, Davis RJ (2007). The JNK signal transduction pathway. Curr Opin Cell Biol 19, 142-149.
35. Yasui K, Imoto I, Fukuda Y, Pimkhaokham A, Yand ZQ, Naruto T, Shimada Y, Nakamura Y, Inazawa J (2001). Identifi cation of target genes within an amplicon at 14q12-q13 in esophageal squamous cell carcinoma. Genes Chromosomes Cancer 32, 112-118.
36. Yu C, Minemoto Y, Zhang J, Liu J, Tang F, Bui TN, Xiang J, Lin A (2004). JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell 13, 329-340. (Pubitemid 38229806)
37. Zhang J, Liu J, Yu C, Lin A (2005). BAD Ser128 is not phosphorylated by c-Jun NH2-terminal kinase for promoting apoptosis. Cancer Res 65, 8372-8378.
38. Zhang S, Lin Y, Kim YS, Hande MP, Liu ZG, Shen HM (2007). c-Jun N-terminal kinase mediates hydrogen peroxide-induced cell death via sustained poly(ADP-ribose) polymerase-1 activation. Cell Death Differ 14, 1001-1010.
39. Zheng C, Xiang J, Hunter T, Lin A (1999). The JNKK2-JNK1 fusion protein acts as a constitutively active c-Jun kinase that stimulates c-Jun transcription activity. J Biol Chem 274, 28966-28971.
40. Zhou M, Gu L, Yeager AM, Findley HW (1998). Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression. Leukemia 12, 1756-1763.
41. Zhu N, Cui J, Qiao C, Li Y, Ma Y, Zhang J, Shen B (2008). cAMP modulates macrophage development by suppressing M-CSF-induced MAPKs activation. Cell Mol Immunol 5, 153-157.